Cited 0 times in Scipus Cited Count

Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study

DC Field Value Language
dc.contributor.authorChoi, TW-
dc.contributor.authorWon, JH-
dc.contributor.authorJae, HJ-
dc.contributor.authorJeon, YS-
dc.contributor.authorPark, SW-
dc.contributor.authorKo, GY-
dc.contributor.authorYim, NY-
dc.contributor.authorWon, JY-
dc.contributor.authorKim, CW-
dc.contributor.authorKim, J-
dc.date.accessioned2024-07-10T03:11:20Z-
dc.date.available2024-07-10T03:11:20Z-
dc.date.issued2024-
dc.identifier.issn1229-6929-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/32649-
dc.description.abstractObjective: To evaluate the safety and clinical outcomes of the Passeo-18 Lux drug-coated balloon (DCB) in endovascular revascularization procedures under real-world conditions in a Korean population with atherosclerotic disease of the infrainguinal arteries, including below-the-knee (BTK) arteries. Materials and Methods: Eight institutions in the Republic of Korea participated in this prospective, multicenter, single-arm, post-market surveillance study. Two hundred patients with Rutherford class 2–5 peripheral arterial disease and infrainguinal lesions suitable for endovascular treatment were competitively enrolled. Data were collected at baseline, the time of intervention, discharge, and 1-, 6-, 12-, and 24-month follow-up visits. The primary safety endpoint was freedom from major adverse events (MAE) within 6 months (except when limiting the time frame for procedure-or device-related mortality to within 30 days), and the primary effectiveness endpoint was freedom from clinically driven target lesion revascularization (CDTLR) within 12 months after the procedure. Results: A total of 197 patients with 332 target lesions were analyzed. Two-thirds of the patients had diabetes mellitus, and 41.6% had chronic limb-threatening ischemia. The median target lesion length was 100 mm (interquartile range: 56–133 mm). Of the target lesions, 35.2% were occlusions, and 14.8% were located in the BTK arteries. Rate of freedom from MAE was 97.9% at 6 months, and the rate of freedom from CD-TLR was 95.0% and 92.2% at 12 and 24 months, respectively. Subgroup analysis of 43 patients and 49 target lesions involving the BTK arteries showed rate of freedom from MAE of 92.8% at 6 months and rates of freedom from CD-TLR of 88.8% and 84.4% at 12 and 24 months, respectively. Conclusion: The results of the present study, including the BTK subgroup analysis, showed outcomes comparable to those of other DCB studies, confirming the safety and effectiveness of Passeo-18 Lux DCB in the Korean population.-
dc.language.isoen-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHAngioplasty, Balloon-
dc.subject.MESHCoated Materials, Biocompatible-
dc.subject.MESHEndovascular Procedures-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPeripheral Arterial Disease-
dc.subject.MESHProduct Surveillance, Postmarketing-
dc.subject.MESHProspective Studies-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHTreatment Outcome-
dc.titleSafety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study-
dc.typeArticle-
dc.identifier.pmid38807338-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136951-
dc.subject.keywordBelow-the-knee-
dc.subject.keywordDrug-coated balloon-
dc.subject.keywordKorean-
dc.subject.keywordPeripheral artery disease-
dc.contributor.affiliatedAuthorChoi, TW-
dc.contributor.affiliatedAuthorWon, JH-
dc.contributor.affiliatedAuthorKim, J-
dc.type.localJournal Papers-
dc.identifier.doi10.3348/kjr.2024.0099-
dc.citation.titleKorean journal of radiology-
dc.citation.volume25-
dc.citation.number6-
dc.citation.date2024-
dc.citation.startPage565-
dc.citation.endPage574-
dc.identifier.bibliographicCitationKorean journal of radiology, 25(6). : 565-574, 2024-
dc.identifier.eissn2005-8330-
dc.relation.journalidJ012296929-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiology
Files in This Item:
38807338.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse